Immediate Impact

1 by Nobel laureates 2 from Science/Nature 68 hit
Sub-graph 1 of 22

Citing Papers

Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Hit
Photocatalytic Late-Stage C–H Functionalization
2023 Hit
2 intermediate papers

Works of Ute Egerland being referenced

Fluorine‐Containing 6,7‐Dialkoxybiaryl‐Based Inhibitors for Phosphodiesterase 10 A: Synthesis and in vitro Evaluation of Inhibitory Potency, Selectivity, and Metabolism
2014
Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia
2009

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ute Egerland 464 247 199 136 56 27 664
Thomas A. Chappie 397 0.9× 218 0.9× 161 0.8× 102 0.8× 38 0.7× 12 578
Loan Miller 211 0.5× 121 0.5× 173 0.9× 145 1.1× 72 1.3× 23 707
B A Hemsworth 275 0.6× 143 0.6× 89 0.4× 229 1.7× 23 0.4× 34 566
Ulrich Schacht 228 0.5× 95 0.4× 117 0.6× 182 1.3× 36 0.6× 44 619
Heather Valentine 299 0.6× 139 0.6× 75 0.4× 205 1.5× 67 1.2× 40 742
George Grayson 239 0.5× 361 1.5× 119 0.6× 231 1.7× 45 0.8× 12 793
Carol B. Fox 445 1.0× 113 0.5× 170 0.9× 346 2.5× 33 0.6× 19 693
Jole Fiorito 348 0.8× 154 0.6× 101 0.5× 120 0.9× 47 0.8× 19 646
Michael Cain 417 0.9× 76 0.3× 275 1.4× 224 1.6× 44 0.8× 15 673
Susan Nielsen 247 0.5× 170 0.7× 54 0.3× 153 1.1× 83 1.5× 27 755

All Works

Loading papers...

Rankless by CCL
2026